Elevated cytokine levels were attributed to high Galectin-3 signaling, and strategies targeting its expression have been shown to be sufficient in decreasing levels of inflammatory cytokines, thereby ameliorating MG-mediated pathogenesis (48). This evidence concerns the gene LGALS3 and myasthenia gravis.